e-learning
resources
Paris 2018
Monday, 17.09.2018
Improving the quality of life of patients with bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung function decline in patients with bronchiectasis
A. Ikan (Haifa, Israel), Y. Adir (Haifa, Israel), N. Stein (Haifa, Israel), S. Schneer (Haifa, Israel), M. Shteinberg (Haifa, Israel)
Source:
International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Session:
Improving the quality of life of patients with bronchiectasis
Session type:
Thematic Poster
Number:
2668
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Ikan (Haifa, Israel), Y. Adir (Haifa, Israel), N. Stein (Haifa, Israel), S. Schneer (Haifa, Israel), M. Shteinberg (Haifa, Israel). Lung function decline in patients with bronchiectasis. 2668
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Lung function at patients with sarcoidosis
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002
Lung function decline in asthma
Source: Eur Respir J 2007; 30: 411-413
Year: 2007
DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015
Lung function decline in COPD trials
Source: Eur Respir J 2009; 33: 708-709
Year: 2009
Predicted postoperative FEV1, DLCO and VO2 underestimate the postoperative values after lung resection in patients with symptomatic non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Maximal ventilatory pressure and pulmonary function in subjects with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Lung function decline in a modern cystic fibrosis cohort
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis
Year: 2012
Lung function and haematological changes in patients with sarcoidosis
Source: Eur Respir J 2007; 30: Suppl. 51, 116s
Year: 2007
Lung comparative function in COPD patients and in patients with chronic airflow obstruction due to tuberculosis lung disorder
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006
Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Lung function in patients with bronchiectasis is preserved by periodical treatment with antibiotics
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Association between sputum cytology and lung function in patients with asthma and COPD
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015
Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Effect of baseline FVC on lung function decline with nintedanib in patients with IPF
Source: International Congress 2015 – Treatment of IPF
Year: 2015
Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015
Tracking pulmonary exacerbations in preschool children using the lung clearance index
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Lung function decline in long-term follow-up of bronchial asthma
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Lung clearance index during pulmonary exacerbation in school-age children with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept